Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: Review of the evidence
Authors:
- Charles A. InderjeethCICharles A. Inderjeeth
- Adrian C.H. FooAFAdrian C.H. Foo
- Michelle M.Y. LaiMLMichelle M.Y. Lai
- Paul GlendenningPGPaul Glendenning
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Shifting the focus in fracture prevention from osteoporosis to fallsBMJ, 2008
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureNew England Journal of Medicine, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Clodronate Reduces the Incidence of Fractures in Community-Dwelling Elderly Women Unselected for Osteoporosis: Results of a Double-Blind, Placebo-Controlled Randomized StudyJournal of Bone and Mineral Research, 2007
- Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analysesBMJ, 2006
- Safety and Efficacy of Teriparatide in Elderly Women with Established Osteoporosis: Bone Anabolic Therapy from a Geriatric PerspectiveJournal of the American Geriatrics Society, 2006
- HIP FRACTURES: CHANGING PATTERNS IN HOSPITAL BED USE IN NSW BETWEEN 1979 AND 1990Anz Journal of Surgery, 1993
- The Future of Hip Fractures in the United StatesClinical Orthopaedics and Related Research, 1990
- Risk Factors for Falls among Elderly Persons Living in the CommunityNew England Journal of Medicine, 1988
- Age and bone mass as predictors of fracture in a prospective study.Journal of Clinical Investigation, 1988